🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05357456
Recruiting Observational

Performances on Cognitive Functions and Brain Function and Follow-up After Different Treatments in Patients With Autonomous Cortisol Secretion: a Single-center, Prospective, Observational Study

NCT05357456 · tracked via the Priya Life Science China tracker
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase
Observational
Started
2021-10-01
Last updated
2022-05-02

Condition(s) studied

Autonomous Cortisol SecretionAdrenal IncidentalomaNon-functioning Adrenal Adenomas

Investigational drug(s) / intervention(s)

Cognitive function assessment; functional magnetic resonance imaginglaparoscopic adrenal surgery

Cognitive function assessment; functional magnetic resonance imaging: cognitive function measurement

laparoscopic adrenal surgery: Only a subgroup of the autonomous cortisol secretion patients will have the laparoscopic adrenal surgery

Study summary

This is a single center, prospective, observational study to explore and evaluate the differences on cognitive function and brain function by functional-MRI in autonomous cortisol secretion patients, and the different treatments methods on the cognitive function and brain function in patients with autonomous cortisol secretion

Eligibility

Sex
ALL
Min age
20 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * age 20-65 years; * ≥ 6 years of education; * right-handed; * complete entire cognitive function tests; * adrenal lesions ≥ 1 cm in diameter; * patients with non-functioning adrenal adenomas; * patients with autonomous cortisol secretion. Exclusion Criteria: * \< 6 years of education; * age \< 20 years or \> 65 years; * maximum diameter of AI \<1cm; * active malignancies; * with a history of thyroid disease; * with a history of acute infection in the last month; * central nervous system diseases, including brain trauma, intracranial hemorrhage, acute cerebral infarction, etc; * contraindications of MRI examination: such as implantation of metal prosthesis in vivo, claustrophobia, etc; * adrenal tuberculosis; * suspected or diagnosed adrenocortical carcinoma; * unable to complete entire cognitive function tests; * current use of steroids or any drugs known to alter steroid synthesis or metabolism in the previous 3 months; * clinical Cushing syndrome; * Cushing disease; * primary hyperaldosteronism; * pheochromocytoma; * severe impairment of heart, liver, kidney and other organs; * pregnant and lactating women

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Endocrinology, Drum Tower Hospital affiliated to Nanjing University Medical School Nanjing Jiangsu Recruiting

More The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05357456 on ClinicalTrials.gov ↗ ← All trials in China